Gw&K Investment Management, LLC Amicus Therapeutics, Inc. Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$8.74 - $11.84 $4,238 - $5,742	-485 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$9.2 - $23.86 $3.98 Million - $10.3 Million	-432,318 Reduced 99.89%	485 $5,000
Q4 2020 Feb 05, 2021	SELL	$13.47 - $24.89 $119,963 - $221,670	-8,906 Reduced 2.02%	432,803 $9.99 Million
Q3 2020 Nov 10, 2020	SELL	$12.89 - $15.89 $111,717 - $137,718	-8,667 Reduced 1.92%	441,709 $6.24 Million
Q2 2020 Aug 06, 2020	SELL	$8.86 - $15.69 $895,967 - $1.59 Million	-101,125 Reduced 18.34%	450,376 $6.79 Million
Q1 2020 May 11, 2020	SELL	$6.63 - $11.16 $190,930 - $321,385	-28,798 Reduced 4.96%	551,501 $5.1 Million
Q4 2019 Feb 10, 2020	SELL	$7.48 - $10.75 $239,202 - $343,774	-31,979 Reduced 5.22%	580,299 $5.65 Million
Q3 2019 Nov 05, 2019	BUY	$8.02 - $13.25 $1.45 Million - $2.4 Million	181,060 Added 41.99%	612,278 $4.91 Million
Q2 2019 Aug 06, 2019	SELL	$10.96 - $14.4 $49,002 - $64,382	-4,471 Reduced 1.03%	431,218 $5.38 Million
Q1 2019 May 14, 2019	SELL	$10.04 - $13.92 $675,631 - $936,732	-67,294 Reduced 13.38%	435,689 $5.93 Million
Q4 2018 Feb 07, 2019	SELL	$8.38 - $13.44 $43,157 - $69,216	-5,150 Reduced 1.01%	502,983 $4.82 Million
Q3 2018 Nov 06, 2018	BUY	$11.6 - $16.54 $2.49 Million - $3.55 Million	214,421 Added 73.0%	508,133 $6.14 Million
Q2 2018 Aug 07, 2018	SELL	$13.13 - $17.09 $41,740 - $54,329	-3,179 Reduced 1.07%	293,712 $4.59 Million
Q1 2018 May 08, 2018	SELL	$13.76 - $17.12 $6,302 - $7,840	-458 Reduced 0.15%	296,891 $4.47 Million
Q4 2017 Jan 19, 2018	BUY	$12.51 - $16.24 $278,835 - $361,973	22,289 Added 8.1%	297,349 $4.28 Million
Q3 2017 Oct 11, 2017	BUY	$11.74 - $15.78 $3.23 Million - $4.34 Million	275,060	275,060 $4.15 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$277 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$270 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$234 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$230 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$223 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account